BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21644045)

  • 1. A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis.
    Mishra R; Singh A; Chandra V; Negi MP; Tripathy BC; Prakash J; Gupta V
    Rheumatol Int; 2012 Aug; 32(8):2377-82. PubMed ID: 21644045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red Blood Cell Distribution Width in Rheumatoid Arthritis, Ankylosing Spondylitis and Osteoarthritis: True Inflammatory Index or Effect of Anemia?
    Lin F; Wang X; Liang Y; Liu D; Zhang Y; Zhong R; Yang Z
    Ann Clin Lab Sci; 2018 May; 48(3):301-307. PubMed ID: 29970432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy.
    Curtis JR; John A; Baser O
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1282-91. PubMed ID: 22504829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and synovial fluid concentrations of cold-inducible RNA-binding protein in patients with rheumatoid arthritis.
    Yoo IS; Lee SY; Park CK; Lee JC; Kim Y; Yoo SJ; Shim SC; Choi YS; Lee Y; Kang SW
    Int J Rheum Dis; 2018 Jan; 21(1):148-154. PubMed ID: 27315340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels.
    Andrés Cerezo L; Kuklová M; Hulejová H; Vernerová Z; Pešáková V; Pecha O; Veigl D; Haluzík M; Pavelka K; Vencovský J; Senolt L
    Cytokine; 2013 Oct; 64(1):441-7. PubMed ID: 23714112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant levels of natural IgM antibodies in osteoarthritis and rheumatoid arthritis patients in comparison to healthy controls.
    Nguyen TG; McKelvey KJ; March LM; Hunter DJ; Xue M; Jackson CJ; Morris JM
    Immunol Lett; 2016 Feb; 170():27-36. PubMed ID: 26744098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
    Kizaki K; Yamashita F; Hayashi T; Funakoshi N
    Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cell-derived microparticles in synovial fluid and plasma of patients with rheumatoid arthritis.
    Michael BNR; Kommoju V; Kavadichanda Ganapathy C; Negi VS
    Rheumatol Int; 2019 Aug; 39(8):1377-1387. PubMed ID: 31201512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
    Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
    Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis.
    Dessein PH; Stanwix AE; Joffe BI
    Arthritis Res; 2002; 4(5):R5. PubMed ID: 12223108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor activator of nuclear factor kappa B ligand serum and synovial fluid level. A comparative study between rheumatoid arthritis and osteoarthritis.
    Ellabban AS; Kamel SR; Ahmed SS; Osman AM
    Rheumatol Int; 2012 Jun; 32(6):1589-96. PubMed ID: 21328055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherogenic lipid profile and high sensitive C-reactive protein in patients with rheumatoid arthritis.
    Singh HV; Shrivastava AK; Raizada A; Singh SK; Pandey A; Singh N; Yadav D; Sharma H
    Clin Biochem; 2013 Aug; 46(12):1007-1012. PubMed ID: 23578742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis.
    Sarban S; Kocyigit A; Yazar M; Isikan UE
    Clin Biochem; 2005 Nov; 38(11):981-6. PubMed ID: 16150434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Tryptophan-related Metabolomic Profile in Rheumatoid Arthritis Synovial Fluid.
    Kang KY; Lee SH; Jung SM; Park SH; Jung BH; Ju JH
    J Rheumatol; 2015 Nov; 42(11):2003-11. PubMed ID: 26329338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistin in inflammatory and degenerative rheumatologic diseases. Relationship between resistin and rheumatoid arthritis disease progression.
    Fadda SM; Gamal SM; Elsaid NY; Mohy AM
    Z Rheumatol; 2013 Aug; 72(6):594-600. PubMed ID: 23471526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis.
    George MD; Giles JT; Katz PP; England BR; Mikuls TR; Michaud K; Ogdie-Beatty AR; Ibrahim S; Cannon GW; Caplan L; Sauer BC; Baker JF
    Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1789-1798. PubMed ID: 28393498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis.
    Penatti A; Facciotti F; De Matteis R; Larghi P; Paroni M; Murgo A; De Lucia O; Pagani M; Pierannunzii L; Truzzi M; Ioan-Facsinay A; Abrignani S; Geginat J; Meroni PL
    Arthritis Res Ther; 2017 May; 19(1):103. PubMed ID: 28526072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between systemic inflammation and autoimmunity parameters and plasma lipid in patients with rheumatoid arthritis].
    Xue C; Liu WL; Sun YH; Ding RJ; Hu DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):941-5. PubMed ID: 22321280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis.
    Myngbay A; Bexeitov Y; Adilbayeva A; Assylbekov Z; Yevstratenko BP; Aitzhanova RM; Matkarimov B; Adarichev VA; Kunz J
    Front Immunol; 2019; 10():1353. PubMed ID: 31249576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.